Migalastat

DRUG3 trials

Sponsors

Manchester University NHS Foundation Trust, Amicus Therapeutics, Sanofi

Conditions

Fabry Disease

Phase 3

A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease

Active, not recruitingNCT05280548

SanofiFabry Disease

Start: 2022-05-03End: 2027-12-06Updated: 2026-03-10

Unknown Phase

A Study of Migalastat in Fabry Disease

Manchester University NHS Foundation TrustFabry Disease

Start: 2019-05-16End: 2023-12-31Updated: 2023-05-31

A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding

RecruitingNCT04252066

Amicus TherapeuticsFabry Disease

Start: 2025-03-18End: 2030-02-28Target: 20Updated: 2025-07-08